CTRI/2008/091/000213已完成4 期
XIENCE V Everolimus Eluting Coronary Stent System (EECSS) India Post-Marketing Registry
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •The patient agrees to participate in this study by signing the EC approved informed consent form. Alternatively, the patient's legally authorized representative agrees to the patient's participation in this study and signs the informed consent form
排除标准
- •The inability to obtain an informed consent is an exclusion criterion
研究者
相似试验
已完成
4 期
XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval Randomized Control Trial (RCT)Coronary OcclusionThrombosis (Stent Thrombosis)Vascular DiseaseCoronary Artery StenosisCoronary DiseaseCoronary RestenosisCoronary Artery DiseaseMyocardial IschemiaNCT01178268Abbott Medical Devices546
已完成
不适用
XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval, Single-Arm StudyAngioplastyChronic Coronary OcclusionStent ThrombosisVascular DiseaseCoronary Artery StenosisCoronary DiseaseCoronary RestenosisCoronary Artery DiseaseMyocardial IschemiaNCT01249027Abbott Medical Devices2,605
已完成
不适用
XIENCE V® EXCEED: Evaluation of XIENCE V® Catheterization Lab Endpoints and Excellence in DeliveryAtherosclerosisCoronary Artery DiseaseNCT00731237Abbott Medical Devices2,517
已完成
不适用
BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) European Angiography Studycoronary artery diseasecoronary artery stenosis10011082NL-OMON47919Medinol Lid.49
已完成
不适用
BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) In Coronary Stenosis Trialcoronary artery diseasecoronary artery stenosis10011082NL-OMON47650Medinol Ltd.119